GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Gujarat Kidney and Super Speciality Ltd

Gujarat Kidney And Super Speciality Ltd to consider Q2 FY27 results on Nov 4, 2026

BOARD ● No Immediate Change LOW RISK
📅 Filed on BSE: 23 Oct 2026, 06:20 PM IST  ·  BSE ID: 3b600589-62c1-485d-a571-ce35a510b69b
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's directors will meet to review and approve financial results for the July to September 2026 period.
🤖 AI Summary
  • Board meeting scheduled for November 04, 2026, to approve Q2 FY27 financial results.
  • Unaudited standalone and consolidated financial results for September 30, 2026, quarter to be considered.
  • Trading window closed from October 1, 2026, until 48 hours post-results announcement.
  • Company confirms adherence to SEBI (Prohibition of Insider Trading) Regulations, 2015.
🏢 How This Affects the Company
⚙️
Operational Impact
The company will implement a temporary closure of its trading window for designated persons to prevent insider trading during financial result disclosure.
⚠️
Risk Impact
Manages regulatory risk by adhering to SEBI's insider trading norms and timely disclosure requirements.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders at this time. Shareholders should await the announcement of financial results.
👤
Who Is Affected
All shareholders will be affected by the information disclosed in the unaudited financial results for the quarter ended September 30, 2026.
🔍
Management Signal
Management is adhering to regulatory requirements for timely financial reporting and insider trading prevention.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Board meeting on November 04, 2026, to approve Q2 FY27 results.
Announcement of unaudited financial results for September 30, 2026, quarter.
Lifting of the trading window closure post-results announcement.
LOW RISK Filing is a routine procedural announcement for a board meeting.
💡 Investor Takeaway
Gujarat Kidney And Super Speciality Ltd announced a Board Meeting on November 04, 2026, to consider unaudited financial results for the quarter ended September 30, 2026.
❓ Frequently Asked Questions
When will Gujarat Kidney And Super Speciality Ltd announce its Q2 FY27 financial results?
Gujarat Kidney And Super Speciality Ltd's Board of Directors will consider the unaudited financial results for the quarter ended September 30, 2026, on November 04, 2026.
What is the purpose of the Gujarat Kidney And Super Speciality Ltd Board Meeting on November 04, 2026?
The Board Meeting is scheduled to consider and approve the unaudited standalone and consolidated financial results for the quarter ended September 30, 2026.
When is the trading window closed for Gujarat Kidney And Super Speciality Ltd?
The trading window for Gujarat Kidney And Super Speciality Ltd is closed from October 1st, 2026, until 48 hours after the announcement of the unaudited financial results for the quarter ended September 30, 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.